OneSource Speci.

{
  "main_header": {
    "sid": 10039523,
    "name": "OneSource Speci.",
    "stock_name": "OneSource Speci.",
    "full_name": "OneSource Specialty Pharma Ltd",
    "name_url": "stocks-analysis/onesource-speci",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,641.00",
    "chg": -12.8,
    "chgp": "-0.77%",
    "dir": -1,
    "prev_price": "1,653.80",
    "mcapval": "18,813.38 Cr",
    "mcap": "Small Cap",
    "scripcode": 544292,
    "symbol": "ONESOURCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE013P01021",
    "curr_date": "Jul 24, 11:47 AM",
    "curr_time": "11:48 AM",
    "last_traded_at": "Jul 24, 11:47 AM IST",
    "bse_nse_vol": "18.47 k",
    "exc_status": "Active",
    "traded_date": "Jul 24, 2026",
    "traded_date_str": "2026 07 24",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/onesource-speci-10039523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "OneSource Specialty Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-4118683",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/OneSourceSpecia_technicaldot_4118683.png",
        "date": "2026-07-24 08:03:55",
        "description": "OneSource Specialty Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of indicator signals. Despite a recent downgrade in its Mojo Grade from Sell to Hold, the stock’s price action and technical indicators suggest a cautious outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Upgraded to Hold Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/onesource-specialty-pharma-ltd-upgraded-to-hold-amid-mixed-financial-and-technical-signals-4117269",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/OneSourceSpecia_mojoScore_4117269.png",
        "date": "2026-07-23 08:34:30",
        "description": "OneSource Specialty Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators and financial trends despite ongoing challenges in profitability and valuation. The upgrade, effective from 22 July 2026, is driven primarily by a shift in technical momentum and a stabilisation in long-term sales growth, signalling cautious optimism for investors in this small-cap pharmaceutical player."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-shows-mildly-bullish-momentum-amid-mixed-technical-signals-4117153",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/OneSourceSpecia_technicaldot_4117153.png",
        "date": "2026-07-23 08:05:29",
        "description": "OneSource Specialty Pharma Ltd has shifted from a sideways technical trend to a mildly bullish stance, reflecting a nuanced change in price momentum. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent performance suggests cautious optimism for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "When is the next results date for OneSource Specialty Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-onesource-specialty-pharma-ltd-4114212",
        "imagepath": "",
        "date": "2026-07-21 23:17:27",
        "description": "The next results date for OneSource Specialty Pharma Ltd is scheduled for July 24, 2026...."
      },
      {
        "title": "OneSource Specialty Pharma Gains 2.19%: Technical Shifts and Downgrade Shape Weekly Moves",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-gains-219-technical-shifts-and-downgrade-shape-weekly-moves-4106866",
        "imagepath": "",
        "date": "2026-07-18 10:00:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Jul:</strong> Downgrade to Sell rating announced amid weak financials and technical signals</p>\n                    <p><strong>13 Jul:</strong> Technical momentum shift from mildly bullish to sideways trend observed</p>\n                    <p><strong>17 Jul:</strong> Week closes at Rs.1,650.45, up 2.19% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,615.10</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,650.45</div><div class=\"stat-change positive\">+2.19%</div>..."
      },
      {
        "title": "OneSource Specialty Pharma Downgraded to Sell Amid Weak Financials and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/onesource-specialty-pharma-downgraded-to-sell-amid-weak-financials-and-technical-signals-4097898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/OneSourceSpecia_mojoScore_4097898.png",
        "date": "2026-07-13 08:13:35",
        "description": "OneSource Specialty Pharma Ltd has seen its investment rating downgraded from Hold to Sell as of 10 July 2026, reflecting deteriorating technical indicators, weak financial trends, and valuation concerns. The company’s Mojo Score has declined to 41.0, signalling caution for investors amid a challenging market environment and underwhelming operational performance."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Faces Technical Momentum Shift Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-faces-technical-momentum-shift-amid-bearish-signals-4097856",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/OneSourceSpecia_technicaldot_4097856.png",
        "date": "2026-07-13 08:04:43",
        "description": "OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators reveal a complex picture with bearish signals dominating weekly charts, raising concerns about the stock’s near-term trajectory amid broader market pressures."
      },
      {
        "title": "OneSource Specialty Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/onesource-specialty-pharma-ltd-is-rated-sell-4096973",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/OneSourceSpecia_mojoScore_4096973.png",
        "date": "2026-07-11 10:10:18",
        "description": "OneSource Specialty Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "OneSource Specialty Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/onesource-specialty-pharma-ltd-is-rated-hold-4078832",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/OneSourceSpecia_mojoScore_4078832.png",
        "date": "2026-06-30 10:10:03",
        "description": "OneSource Specialty Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 Jun 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 235,
    "sid": "10039523",
    "stock_news_url": "https://www.marketsmojo.com/news/onesource-specialty-pharma-10039523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "21-Jul-2026",
      "details": "Intimation of Earnings Call to be held on July 25 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2026.",
      "datetime": "20-Jul-2026",
      "details": "Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 inter alia to consider and approve Unaudited financial results (Standalone and Consolidated) for the quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Onesource Specialty Pharma And Formycon AG Announce Strategic Manufacturing Partnership For Biosimilars",
      "datetime": "14-Jul-2026",
      "details": "OneSource Specialty Pharma and Formycon AG announce Strategic Manufacturing Partnership for Biosimilars",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(24 Jul 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

OneSource Specialty Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-07-24 08:03:55

OneSource Specialty Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of indicator signals. Despite a recent downgrade in its Mojo Grade from Sell to Hold, the stock’s price action and technical indicators suggest a cautious outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

OneSource Specialty Pharma Ltd Upgraded to Hold Amid Mixed Financial and Technical Signals

2026-07-23 08:34:30

OneSource Specialty Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators and financial trends despite ongoing challenges in profitability and valuation. The upgrade, effective from 22 July 2026, is driven primarily by a shift in technical momentum and a stabilisation in long-term sales growth, signalling cautious optimism for investors in this small-cap pharmaceutical player.

Read full news article

OneSource Specialty Pharma Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals

2026-07-23 08:05:29

OneSource Specialty Pharma Ltd has shifted from a sideways technical trend to a mildly bullish stance, reflecting a nuanced change in price momentum. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent performance suggests cautious optimism for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

When is the next results date for OneSource Specialty Pharma Ltd?

2026-07-21 23:17:27

The next results date for OneSource Specialty Pharma Ltd is scheduled for July 24, 2026....

Read full news article

OneSource Specialty Pharma Gains 2.19%: Technical Shifts and Downgrade Shape Weekly Moves

2026-07-18 10:00:10

Key Events This Week

13 Jul: Downgrade to Sell rating announced amid weak financials and technical signals

13 Jul: Technical momentum shift from mildly bullish to sideways trend observed

17 Jul: Week closes at Rs.1,650.45, up 2.19% for the week

Week Open

Rs.1,615.10

Week Close

Rs.1,650.45

+2.19%

...

Read full news article

OneSource Specialty Pharma Downgraded to Sell Amid Weak Financials and Technical Signals

2026-07-13 08:13:35

OneSource Specialty Pharma Ltd has seen its investment rating downgraded from Hold to Sell as of 10 July 2026, reflecting deteriorating technical indicators, weak financial trends, and valuation concerns. The company’s Mojo Score has declined to 41.0, signalling caution for investors amid a challenging market environment and underwhelming operational performance.

Read full news article

OneSource Specialty Pharma Ltd Faces Technical Momentum Shift Amid Bearish Signals

2026-07-13 08:04:43

OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators reveal a complex picture with bearish signals dominating weekly charts, raising concerns about the stock’s near-term trajectory amid broader market pressures.

Read full news article

OneSource Specialty Pharma Ltd is Rated Sell

2026-07-11 10:10:18

OneSource Specialty Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

OneSource Specialty Pharma Ltd is Rated Hold

2026-06-30 10:10:03

OneSource Specialty Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 Jun 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News